Skip to Main content

Search results for ''...


Sorry, there were no results

Get In Touch

By submitting an enquiry through 'get in touch' your data will only be used to contact you regarding your enquiry. If you would like to receive newsletters from Thomson Snell & Passmore please use the separate form below.

Newsletter Sign Up

I would like to receive newsletters, event invitations and publications from Thomson Snell & Passmore by email on the following topics (tick all those that apply) and consent for my data to be processed for this purpose.

We respect your privacy and want news to be relevant. To either, click here or update your preferences by emailing us at info@ts-p.co.uk. Your personal data shall be treated in accordance with our & .

Get In Touch

By submitting an enquiry through 'get in touch' your data will only be used to contact you regarding your enquiry. If you would like to receive newsletters from Thomson Snell & Passmore please use the separate form below.

Newsletter Sign Up

I would like to receive newsletters, event invitations and publications from Thomson Snell & Passmore by email on the following topics (tick all those that apply) and consent for my data to be processed for this purpose.

We respect your privacy and want news to be relevant. To either, click here or update your preferences by emailing us at info@ts-p.co.uk. Your personal data shall be treated in accordance with our & .

  • Overview

    Thomson Snell & Passmore has advised Centron Diagnostics Ltd, a spin-out company from King's College London, in relation to the sale of its central blood pressure monitoring technology and assets to SunTech Medical Inc, a global leader in clinical-grade, non-invasive blood pressure measurement solutions.

    The technology was developed through research at King's College London and commercialised via Centron and will now be available to health care workers and patients through the sale to SunTech.

    Centron Diagnostics was spun out of King's College London in 2010 with investment from its founders and from Guy's and St Thomas' Charity. King's College London licenced the patented technology to Centron Diagnostics for development and commercialisation, supporting the company in its early stages whilst retaining a shareholding. Certain of the underpinning research was funded by the British Heart Foundation.

    The corporate team at Thomson Snell & Passmore was led by Joanne Gallagher(Partner) who assisted with the intellectual property, contractual and cross-border considerations of the transaction.

  • Related Services

    Commercial

    We draw on our extensive legal, commercial and industry expertise when working with you to achieve your strategic objectives.

Get In Touch

By submitting an enquiry through 'get in touch' your data will only be used to contact you regarding your enquiry. If you would like to receive newsletters from Thomson Snell & Passmore please use the separate form below.

Newsletter Sign Up

I would like to receive newsletters, event invitations and publications from Thomson Snell & Passmore by email on the following topics (tick all those that apply) and consent for my data to be processed for this purpose.

We respect your privacy and want news to be relevant. To either, click here or update your preferences by emailing us at info@ts-p.co.uk. Your personal data shall be treated in accordance with our & .

^
Jargon Buster